{"text": "High GRIm-Score was an independent prognostic biomarker of OS of first-line cytotoxic chemotherapy for wild-type EGFR adenocarcinoma and of PFS of first- or second-generation EGFR-TKI for EGFR-mutant NSCLC. Therefore, GRIm-Score is not only a specific selection marker for experimental immunotherapy trials, but may also be a promising and useful pretreatment prognostic maker for specific NSCLC subsets in the real-world practice.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 113, "end": 132}}, {"id": "T2", "obj": "disease", "span": {"begin": 188, "end": 205}}, {"id": "T3", "obj": "disease", "span": {"begin": 390, "end": 395}}]}
